Appco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for APPCO
APPCO has twenty-four approved drugs.
There is one tentative approval on APPCO drugs.
Summary for Appco
| US Patents: | 0 |
| Tradenames: | 23 |
| Ingredients: | 23 |
| NDAs: | 24 |
| Patent Litigation for Appco: | See patent lawsuits for Appco |
Drugs and US Patents for Appco
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Appco | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 207178-001 | Mar 2, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Appco | FLUVOXAMINE MALEATE | fluvoxamine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 220328-002 | Apr 30, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Appco | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 209603-003 | Jun 20, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
